JP7640531B2 - 血液製剤を生産するための材料及び方法 - Google Patents

血液製剤を生産するための材料及び方法 Download PDF

Info

Publication number
JP7640531B2
JP7640531B2 JP2022512705A JP2022512705A JP7640531B2 JP 7640531 B2 JP7640531 B2 JP 7640531B2 JP 2022512705 A JP2022512705 A JP 2022512705A JP 2022512705 A JP2022512705 A JP 2022512705A JP 7640531 B2 JP7640531 B2 JP 7640531B2
Authority
JP
Japan
Prior art keywords
less
composition
platelets
platelet
hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022512705A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020227149A5 (enExample
JP2022532262A (ja
Inventor
ジョシュア ドナルド モンゴメリー
ブレイデン カール イシュラー
スティーブン エドワード エイモス
キース アンドリュー モスコウィッツ
アンバー ニコル リー
ラファエル ホルダ
グレン マイケル フィッツパトリック
マイケル アレクサンダー マシューズ
Original Assignee
セルフィアー インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セルフィアー インコーポレイテッド filed Critical セルフィアー インコーポレイテッド
Publication of JP2022532262A publication Critical patent/JP2022532262A/ja
Publication of JPWO2020227149A5 publication Critical patent/JPWO2020227149A5/ja
Priority to JP2025025854A priority Critical patent/JP2025081548A/ja
Application granted granted Critical
Publication of JP7640531B2 publication Critical patent/JP7640531B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3413—Diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A61M1/382—Optimisation of blood component yield
    • A61M1/385—Optimisation of blood component yield taking into account of the patient characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/12—Addition of chemical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/10—Cross-flow filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00—Microcarriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Water Supply & Treatment (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
JP2022512705A 2019-05-03 2020-05-01 血液製剤を生産するための材料及び方法 Active JP7640531B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025025854A JP2025081548A (ja) 2019-05-03 2025-02-20 血液製剤を生産するための材料及び方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962843061P 2019-05-03 2019-05-03
US62/843,061 2019-05-03
US201962936122P 2019-11-15 2019-11-15
US62/936,122 2019-11-15
PCT/US2020/031172 WO2020227149A1 (en) 2019-05-03 2020-05-01 Materials and methods for producing blood products

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025025854A Division JP2025081548A (ja) 2019-05-03 2025-02-20 血液製剤を生産するための材料及び方法

Publications (3)

Publication Number Publication Date
JP2022532262A JP2022532262A (ja) 2022-07-13
JPWO2020227149A5 JPWO2020227149A5 (enExample) 2023-05-12
JP7640531B2 true JP7640531B2 (ja) 2025-03-05

Family

ID=73017071

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022512705A Active JP7640531B2 (ja) 2019-05-03 2020-05-01 血液製剤を生産するための材料及び方法
JP2025025854A Pending JP2025081548A (ja) 2019-05-03 2025-02-20 血液製剤を生産するための材料及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025025854A Pending JP2025081548A (ja) 2019-05-03 2025-02-20 血液製剤を生産するための材料及び方法

Country Status (11)

Country Link
US (4) US11529587B2 (enExample)
EP (1) EP3962499A4 (enExample)
JP (2) JP7640531B2 (enExample)
KR (1) KR20220016092A (enExample)
CN (1) CN114072159A (enExample)
AU (2) AU2020267368B2 (enExample)
BR (1) BR112021021984A2 (enExample)
CA (1) CA3138529C (enExample)
IL (2) IL322149A (enExample)
SG (1) SG11202112054WA (enExample)
WO (1) WO2020227149A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
CA3121484A1 (en) 2018-11-30 2020-06-04 Cellphire, Inc. Platelets loaded with anti-cancer agents
CN114072159A (zh) 2019-05-03 2022-02-18 塞尔菲乐有限公司 用于生产血液产品的材料和方法
CA3147618A1 (en) * 2019-07-17 2021-01-21 Cellphire, Inc. Use of platelets in treating infections
WO2022178177A1 (en) * 2021-02-17 2022-08-25 Cellphire, Inc. Freeze-dried platelet derivative compositions for treating antiplatelet-induced coagulopathy
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN AGENT FOR REMOVING THE THROMBOCYTE AGGREGATION-INHIBITING EFFECT
WO2023220739A1 (en) 2022-05-12 2023-11-16 Cellphire, Inc. Platelet derivative compositions for use in subjects afflicted with hermansky pudlak syndrome or bernard soulier syndrome
WO2023081804A1 (en) * 2021-11-04 2023-05-11 Cellphire, Inc. Platelet derivative compositions, and methods of making and using such compositions
WO2021158645A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Methods of treating congenital hemophilia with anti-fibrinolytic loaded platelets
US20220273724A1 (en) 2021-02-17 2022-09-01 Cellphire Inc. Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathy
WO2022178191A1 (en) * 2021-02-17 2022-08-25 Cellphire, Inc. Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy
US20240164367A1 (en) * 2021-04-20 2024-05-23 Retham Technologies, Llc Methods for maintaining long-term platelet viability and activatability
CN115462369B (zh) * 2022-09-29 2023-09-22 安徽省立医院(中国科学技术大学附属第一医院) 一种玻璃化冷冻外泌体保存方法
CN121013903A (zh) * 2023-03-08 2025-11-25 艾慕优股份有限公司 用于全血保存的组合物和方法
WO2024192173A1 (en) 2023-03-14 2024-09-19 Cellphire, Inc. Hla-characterized platelet derivative compositions, and methods of making, selecting and using such compositions
WO2024229305A1 (en) 2023-05-03 2024-11-07 Cellphire, Inc. Platelet derivative compositions for use in controlling bleeding in a subject
WO2024233577A1 (en) 2023-05-11 2024-11-14 Vetstem, Inc. Platelet-rich plasma compositions, preparation, and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509924A (ja) 2004-08-12 2008-04-03 アドライフ インコーポレイテッド 凍結乾燥血小板の調製法、凍結乾燥血小板を含む組成物、および使用法
US20120125847A1 (en) 2010-11-23 2012-05-24 Biovec Transfusion, Llc Methods for removing pathogens from a platelet preparation
WO2014084263A1 (ja) 2012-11-30 2014-06-05 東レ株式会社 人工保存液置換血小板溶液の製造方法

Family Cites Families (204)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932943A (en) 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
US3928566A (en) 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
DE2546166A1 (de) 1975-10-15 1977-04-28 Behringwerke Ag Gegerbte thrombozyten
US4059967A (en) 1976-02-19 1977-11-29 The Community Blood Council Of Greater New York, Inc. Process for freezing blood platelets
US4455299A (en) 1981-11-20 1984-06-19 Baxter Travenol Laboratories, Inc. Storage of blood platelets
US4481189A (en) 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4670013A (en) 1982-12-27 1987-06-02 Miles Laboratories, Inc. Container for blood and blood components
US4865871A (en) 1983-08-23 1989-09-12 Board Of Regents The University Of Texas System Method for cryopreparing biological tissue
US5185160A (en) 1984-06-21 1993-02-09 Prp, Inc. Platelet membrane microvesicles
WO1986003122A1 (en) 1984-11-29 1986-06-05 Curatech, Inc. Wound healing agents
US5213814A (en) 1989-04-10 1993-05-25 Cryopharm Corporation Lyophilized and reconstituted blood platelet compositions
US5958670A (en) 1988-05-18 1999-09-28 Cobe Laboratories, Inc. Method of freezing cells and cell-like materials
US4994367A (en) 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5059518A (en) 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
EP0397890B1 (en) 1988-11-18 1994-09-07 Tosoh Corporation Process for purifying blood plasma
US5332578A (en) 1989-04-14 1994-07-26 Prp, Inc. Platelet membrane microparticles
CA2051092C (en) 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
EP0510185B1 (en) 1990-11-07 1996-12-11 Baxter International Inc. Blood platelet storage medium
DK0564502T3 (da) 1990-11-27 2002-05-13 Univ Loyola Chicago Vævsforseglingsmiddel og vækstfaktorholdige præparater, der fremmer accelereret sårheling
GB9114202D0 (en) 1991-07-01 1991-08-21 Quadrant Holdings Cambridge Blood products
JPH07507443A (ja) 1992-01-21 1995-08-24 コーベ　ラボラトリーズ　インコーポレイテッド 細胞および細胞様物質を凍結する方法
US5423738A (en) 1992-03-13 1995-06-13 Robinson; Thomas C. Blood pumping and processing system
EP0642301B1 (en) 1992-05-29 2003-03-12 The University Of North Carolina At Chapel Hill Pharmaceutically acceptable fixed-dried human blood platelets
ATE199626T1 (de) 1993-06-04 2001-03-15 Biotime Inc Plasma-artige lösung
JP3788522B2 (ja) 1994-02-22 2006-06-21 日本電信電話株式会社 血球、幹細胞、および血小板の凍結乾燥生成物の製造方法
EP0668013B1 (en) 1994-02-22 2005-04-20 Nippon Telegraph And Telephone Corporation Freeze-dried blood cells, stem cells and platelets and manufacturing method for the same
US5656598A (en) 1994-03-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Use of fibroblast growth factors to stimulate bone growth
US5759542A (en) 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
US5919614A (en) 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US20010046487A1 (en) 1994-12-30 2001-11-29 Roser Bruce J. Methods for loading platelets, stabilizing platelets for dry storage and compositions obtained thereby
US5736313A (en) 1995-10-20 1998-04-07 The United States Of America As Represented By The Secretary Of The Navy Method of lyophilizing platelets by incubation with high carbohydrate concentrations and supercooling prior to freezing
CA2256333A1 (en) 1996-05-29 1997-12-04 Victor Bronshtein Long-term shelf preservation by vitrification
DE19634313A1 (de) 1996-08-24 1998-02-26 Behringwerke Ag Methode zur Stabilisierung von Plättchen
US5827741A (en) 1996-11-19 1998-10-27 The Regents Of The University Of California Cryopreservation of human adult and fetal pancreatic cells and human platelets
US5817381A (en) 1996-11-13 1998-10-06 Agricultural Utilization Research Institute Cellulose fiber based compositions and film and the process for their manufacture
US6221575B1 (en) 1997-02-07 2001-04-24 Quadrant Holdings Cambridge Ltd. Methods for producing dried storage-stable platelets and compositions obtained thereby
US6139878A (en) 1998-04-27 2000-10-31 Aventis Behring, Llc Method for preparing a diafiltered stabilized blood product
JP2002530353A (ja) 1998-11-20 2002-09-17 イーライ・リリー・アンド・カンパニー ウイルス性出血熱の処置法
WO2000044398A2 (en) 1999-01-28 2000-08-03 Board Of Regents, The University Of Texas System Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
WO2001007921A2 (en) 1999-07-23 2001-02-01 Medical Analysis Systems, Inc. Stabilized coagulation control reagent
US7033603B2 (en) 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
CN1378445B (zh) 1999-08-06 2013-02-06 得克萨斯系统大学评议会 药物释放生物可降解纤维植入物
US6211575B1 (en) 1999-08-18 2001-04-03 Sigmatel Inc. Method and apparatus for identifying customized integrated circuits
ATE236521T1 (de) 1999-11-12 2003-04-15 Elan Drug Delivery Ltd Stabilisierung von blutplättchen
US7208265B1 (en) 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
ITAL990010U1 (it) 1999-12-14 2001-06-14 Maria Cristina Sacchi Nuova metodica di laboratorio per preparare gel e membrane piastriniche ottenute dal concentrato piastrinico.
US6770478B2 (en) 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
US20040147024A1 (en) 2000-02-10 2004-07-29 Crowe John H. Therapeutic platelets and methods
US20020076445A1 (en) 2000-02-10 2002-06-20 Crowe John H. Eukaryotic cells and method for preserving cells
US20040185524A1 (en) 2000-02-10 2004-09-23 Crowe John H. Biological samples and method for increasing survival of biological samples
AU2001234978A1 (en) 2000-02-10 2001-08-20 The Regents Of The University Of California Therapeutic platelets and methods
US20040152964A1 (en) 2000-02-10 2004-08-05 Crowe John H. Method and therapeutic platelets
US7696168B2 (en) 2000-04-21 2010-04-13 Tufts Medical Center, Inc. G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
WO2001089431A1 (en) 2000-05-22 2001-11-29 Coffey Arthur C Combination sis and vacuum bandage and method
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
DE60140219D1 (de) 2000-10-19 2009-11-26 Bracco Imaging Spa Radiopharmazeutische formulierungen
US20050222029A1 (en) 2001-01-04 2005-10-06 Myriad Genetics, Incorporated Compositions and methods for treating diseases
AU2002326717A1 (en) 2001-08-22 2003-03-10 Maxcyte, Inc. Apparatus and method for electroporation of biological samples
JP2006510568A (ja) 2001-11-09 2006-03-30 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドおよびイプシロン―アミノカプロン酸を含む薬学的組成物
US20040136974A1 (en) 2002-01-16 2004-07-15 Crowe John H. Therapeutic platelets and methods
JP2003238174A (ja) 2002-02-15 2003-08-27 Asahi Glass Co Ltd フロートガラスの製造方法
JP2005523128A (ja) 2002-04-24 2005-08-04 インターポア・オルソペディックス 血液分離及び濃縮システム
JP4699028B2 (ja) 2002-11-08 2011-06-08 ザ ブライアム アンド ウィミンズ ホスピタル インコーポレーテッド 血小板の生存を延長するための組成物および方法
AU2003302323A1 (en) 2002-11-29 2004-06-23 The Regents Of The University Of California A method and therapeutic platelets
AU2003304289A1 (en) 2002-11-29 2005-01-21 The Regents Of The University Of California A method and therapeutic platelets
GB0305133D0 (en) 2003-03-06 2003-04-09 Sinvent As Product
US7294455B2 (en) 2003-05-16 2007-11-13 The University Of North Carolina At Chapel Hill Fixed-dried platelets cross-linked to protein
US20050048460A1 (en) 2003-05-29 2005-03-03 The Regents Of The University Of California Preservative and method for preserving cells
US20060200100A1 (en) 2003-06-18 2006-09-07 Rosati Coni F Method and apparatus for supplying gas to an area
JP2005053841A (ja) 2003-08-05 2005-03-03 Kyouto Biomedical Science:Kk 皮膚外用剤
DE10335833A1 (de) 2003-08-05 2005-03-03 Curevac Gmbh Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
WO2005020893A2 (en) 2003-08-06 2005-03-10 The Regents Of The University Of California Therapeutic platelets and methods
GB0323378D0 (en) 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
US20050181978A1 (en) 2003-11-20 2005-08-18 Rasmus Rojkjaer Therapeutic use of factor XI
US7678780B2 (en) 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
US20050191286A1 (en) 2004-02-09 2005-09-01 Gandy James B. Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair
CA2563904A1 (en) 2004-02-18 2005-08-25 Plasma Ventures Pty Ltd Isolated plasma and method for hyperimmunisation and plasma collection
US7811558B2 (en) 2004-08-12 2010-10-12 Cellphire, Inc. Use of stabilized platelets as hemostatic agent
US20060035383A1 (en) 2004-08-12 2006-02-16 David Ho Dry platelet preparations for use in diagnostics
US20060051731A1 (en) 2004-08-12 2006-03-09 David Ho Processes for preparing lyophilized platelets
US20060095121A1 (en) 2004-10-28 2006-05-04 Medtronic Vascular, Inc. Autologous platelet gel on a stent graft
WO2006059329A1 (en) 2004-12-01 2006-06-08 Hadasit Medical Research Services & Development Limited Platelet-derived microparticles for therapy
WO2006091038A1 (en) 2005-02-25 2006-08-31 Medigenes Co., Ltd. Pharmaceutical composition for treating avellino cornea dystrophy comprising blood plasma or serum
US20070166389A1 (en) 2005-08-12 2007-07-19 Bakaltcheva Irina B Stabilized lyophilized blood platelets
US7931919B2 (en) 2005-08-12 2011-04-26 The United States Of America As Represented By The Secretary Of The Army Method of producing glycine-stabilized, lyophilized plasma
WO2007038629A2 (en) 2005-09-26 2007-04-05 Lifecell Corporation Dry platelet composition
US20070087061A1 (en) 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070178104A1 (en) 2006-01-31 2007-08-02 Awdalla Essam T Methods and means for treating solid tumors
WO2007121443A2 (en) 2006-04-17 2007-10-25 Bioe, Inc. Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US20070243137A1 (en) 2006-04-18 2007-10-18 Nanoprobes, Inc. Cell and sub-cell methods for imaging and therapy
US8529958B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US8790924B2 (en) 2006-10-19 2014-07-29 Duke University Reversible platelet inhibition
WO2008073491A1 (en) 2006-12-11 2008-06-19 University Of Florida Research Foundation, Inc. System and method for analyzing progress of labor and preterm labor
US8097403B2 (en) 2006-12-14 2012-01-17 Cellphire, Inc. Freeze-dried platelets, method of making and method of use as a diagnostic agent
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
US20110020107A1 (en) 2007-03-23 2011-01-27 Flodesign Wind Turbine Corporation Molded wind turbine shroud segments and constructions for shrouds
US8512697B2 (en) 2007-05-16 2013-08-20 The University Of North Carolina At Chapel Hill Delivery of micro- and nanoparticles with blood platelets
DE102007028090A1 (de) 2007-06-12 2008-12-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Aktivierbare diagnostische und therapeutische Verbindung
RU2010114013A (ru) 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение нейротрофического фактора для холинергических нейронов сетчатки (nfrcn) и хорионического гонадотропина бета (109-145) в качестве терапевтических средств
US8349367B2 (en) 2007-10-12 2013-01-08 Bakaltcheva Irina B Freeze-dried plasma formats for the trauma care field
WO2009058876A1 (en) 2007-10-29 2009-05-07 Beckman Coulter, Inc. Method for a rapid antibody-based analysis of platelet populations
US20110008804A1 (en) 2007-11-05 2011-01-13 Kain Kevin C Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
TW200930811A (en) 2008-01-04 2009-07-16 Univ Nat Taiwan Science Tech Transfection reagent and method for enhancing transfection efficiency
EP2077118A1 (en) 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
PL2259774T3 (pl) 2008-02-27 2013-04-30 Biomet Biologics Llc Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
US8486619B2 (en) 2008-05-02 2013-07-16 University Of Rochester Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses
US20100055067A1 (en) 2008-08-26 2010-03-04 Snu R&Db Foundation Perfluorocarbon conjugate as a blood substitute
WO2010046949A1 (ja) 2008-10-22 2010-04-29 Inui Hiroaki 細胞をガラス化保存する方法および細胞のガラス化保存用容器
EP2391341A4 (en) 2009-01-30 2012-05-09 Cuthbert O Simpkins REVIVAL LIQUID
EP2427545A1 (en) 2009-05-07 2012-03-14 Gamida Cell Ltd. Methods for selecting expanded stem cell populations
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
EP2266635A1 (en) 2009-06-26 2010-12-29 Aarhus Universitet Three-dimensional nanostructured hybrid scaffold and manufacture thereof
WO2011020107A2 (en) 2009-08-14 2011-02-17 Georgetown University Compositions and methods for detection and treatment of breast cancer
WO2011083472A2 (en) 2010-01-07 2011-07-14 Core Dynamics Ltd. Method for preserving cancellous bone samples and preserved cancellous bone tissue
US20110183311A1 (en) 2010-01-27 2011-07-28 David Ho Dry platelet preparations for use in diagnostics
US9943075B2 (en) 2010-02-17 2018-04-17 Hememics Biotechnologies, Inc. Preservation solutions for biologics and methods related thereto
EP2555918A1 (en) 2010-04-06 2013-02-13 Genvault Corporation Stabilized chemical dehydration of biological material
US9061043B2 (en) 2010-10-13 2015-06-23 Duke University Aptamers to glycoprotein VI
WO2012051571A2 (en) 2010-10-14 2012-04-19 Regado Biosciences, Inc. Nucleic acid modulators of clec-2
US20140083628A1 (en) 2012-09-27 2014-03-27 Velico Medical, Inc. Spray drier assembly for automated spray drying
US20120134974A1 (en) 2010-11-30 2012-05-31 Biovec Transfusion, Llc Methods for removing plasma
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
JP2012143554A (ja) 2010-12-24 2012-08-02 Toray Ind Inc ポリスルホン系中空糸膜及び血小板浮遊液浄化用中空糸膜モジュール並びに血小板浮遊液の浄化方法
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
US20120321722A1 (en) 2011-05-17 2012-12-20 Qiyong Peter Liu Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor
CN108671224B (zh) 2011-06-27 2022-12-13 爱默蕾大学 血小板裂解物的组合物、用途和制备
SG10201601960SA (en) 2011-09-14 2016-04-28 American Regenerative Technologies Llc Inhalation systems, breathing apparatuses, and methods
KR101410065B1 (ko) 2011-12-09 2014-06-27 테고사이언스 (주) 세포의 유용물질을 상온에서 안정하게 보존하는 방법
US9682104B2 (en) 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
CN103524613A (zh) 2012-07-04 2014-01-22 晶光源生技股份有限公司 皮肤更新生长因子及其于皮肤保养的用途及含其的保养品
WO2014051537A1 (en) 2012-09-25 2014-04-03 Biovec Transfusion, Llc Device and method for removing additives in the blood products
CA2887067A1 (en) 2012-10-04 2014-04-10 Genesys Research Institute Platelet compositions and uses thereof
WO2014066142A1 (en) 2012-10-24 2014-05-01 Novamedica Limited Liability Company Nucleic acid regulation of growth arrest-specific protein 6 (gas6)
EP3859004A1 (en) 2012-10-24 2021-08-04 Platelet Targeted Therapeutics LLC Platelet targeted treatment
CN114558032B (zh) 2012-12-21 2025-07-29 安斯泰来再生医药协会 由多能干细胞制备血小板的方法及其组合物
ITRM20130054A1 (it) 2013-01-30 2014-07-31 Paolo Gresele Piastrine trasfettate con materiale genetico esogeno e microparticelle derivate da dette piastrine trasfettate, metodo per la loro preparazione e loro usi.
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
WO2015031347A2 (en) 2013-08-27 2015-03-05 Mayo Foundation For Medical Education And Research Cross-linked platelet material
US20160219870A1 (en) 2013-09-17 2016-08-04 Becton, Dickinson And Company Stabilization of Blood pH During Sample Storage
US20160235781A1 (en) 2013-10-16 2016-08-18 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
JP6762876B2 (ja) 2013-10-29 2020-09-30 ヴァーシティ ブラッド リサーチ インスティチュート ファウンデーション インク ヘパリン誘発性血小板減少症／血栓症を引き起こす血小板活性化抗体を検出する方法
EP3071515A2 (en) 2013-11-18 2016-09-28 Rubius Therapeutics, Inc. Synthetic membrane-receiver complexes
WO2015109220A1 (en) 2014-01-17 2015-07-23 President And Fellows Of Harvard College Platelet decoy and use thereof
CN103907595A (zh) 2014-04-18 2014-07-09 赵树铭 含海藻糖的血小板低温保存液及其应用
WO2015191599A2 (en) 2014-06-09 2015-12-17 Terumo Bct, Inc. Lyophilization
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
EP3155395B1 (en) 2014-06-10 2021-06-02 Biomatrica, INC. Methods and compositions for stabilization of nucleic acids in a blood sample at ambient temperatures
EA201790265A1 (ru) 2014-07-23 2017-07-31 Сирус Корпорейшн Способы получения тромбоцит-содержащих продуктов
US20170274012A1 (en) 2014-09-03 2017-09-28 Entegrion, Inc. Acceleration of Reconstitution of Plasma Powder by Mixing with Small Beads
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
WO2016057041A1 (en) 2014-10-09 2016-04-14 Biovec Transfusion, Llc Compositions and methods for preserving platelet function
CA3005311A1 (en) 2014-11-14 2016-05-19 Cellphire, Inc. Products and devices for controlling and stopping bleeding and methods of using
EP3265116B1 (en) 2015-03-04 2021-06-02 University of Rochester Systemic and topical application of platelet microparticles to treat bleeding in trauma patients
US10897891B2 (en) 2015-04-10 2021-01-26 Board Of Regents, The University Of Texas System Compositions and methods for prolonged cell storage
CA2988610A1 (en) 2015-06-10 2016-12-15 Cellphire, Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
WO2016205009A1 (en) 2015-06-19 2016-12-22 The Regents Of The University Of California Treating infection by a platelet-targeting microbe using nanoparticles
WO2017027760A1 (en) 2015-08-12 2017-02-16 North Carolina State University Platelet membrane-coated drug delivery system
EP3364954A4 (en) 2015-08-28 2019-08-07 Cellphire Inc. PRODUCTS AND METHODS OF USING A PLATELET DERIVATIVE HEMOSTATIC AGENT FOR REGULATING BLEEDING AND ENHANCING HEALING
US20230248772A1 (en) 2015-08-28 2023-08-10 Cellphire, Inc. Products and methods using a platelet-derived hemostatic agent for controlling bleeding and improving healing
EP3368089B1 (en) 2015-10-26 2025-11-05 Translate Bio Ma, Inc. Nanoparticle formulations for delivery of nucleic acid complexes
JP7166169B2 (ja) 2015-11-20 2022-11-07 キアゲン ゲーエムベーハー 細胞外核酸の滅菌のための滅菌組成物を調製する方法
US20190008143A1 (en) 2016-01-14 2019-01-10 Cellphire, Inc. Nucleated cell preservation by lyophilization
US11491186B2 (en) 2016-09-01 2022-11-08 Plas-Free Ltd Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders
TWI670371B (zh) 2016-10-04 2019-09-01 全崴生技股份有限公司 用於細胞冷凍保存的組成物和方法
US20200093853A1 (en) 2016-12-08 2020-03-26 Cellphire, Inc. Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
CA3074712A1 (en) 2017-09-13 2019-03-21 Cellphire, Inc. Canine blood platelet preparations
US20200291356A1 (en) 2019-03-13 2020-09-17 Cellphire, Inc. Canine blood platelet preparations
US20230112136A1 (en) 2017-09-13 2023-04-13 Cellphire, Inc. Canine blood platelet preparations
AU2018335788B2 (en) * 2017-09-22 2024-08-15 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
EP3694322B1 (en) 2017-10-09 2024-07-03 Terumo BCT Biotechnologies, LLC Lyophilization container and method of using same
CN108715834B (zh) 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种富含cd41+、cd81+微囊的血小板裂解液制备方法
CA3107112A1 (en) 2018-07-27 2020-01-30 Cellphire, Inc. Cryopreserved platelet compositions and methods for making
CA3015457A1 (en) 2018-08-24 2020-02-24 Bloodworks Methods to reduce clot formation in cold-stored platelet products
US20200060262A1 (en) 2018-08-24 2020-02-27 Bloodworks Methods to reduce clot formation in cold-stored platelet products
US11088715B2 (en) 2018-08-31 2021-08-10 TE Connectivity Services Gmbh Communication system having a receptacle cage with an airflow channel
EP3849570A4 (en) 2018-09-11 2023-07-12 Cellphire Inc. BLOOD PLASMA COMPOSITIONS
CN109942687B (zh) 2018-10-16 2020-07-03 哈尔滨医科大学 68Ga标记EACA修饰c-Met分子成像探针及制备与应用
US20230248771A1 (en) 2018-11-30 2023-08-10 Cellphire, Inc. Platelets loaded with anti-cancer agents
CA3121484A1 (en) 2018-11-30 2020-06-04 Cellphire, Inc. Platelets loaded with anti-cancer agents
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
WO2020165152A1 (en) 2019-02-13 2020-08-20 Tigenix, S.A.U. Cryopreservation of stem cells
CN114072159A (zh) 2019-05-03 2022-02-18 塞尔菲乐有限公司 用于生产血液产品的材料和方法
CA3147618A1 (en) 2019-07-17 2021-01-21 Cellphire, Inc. Use of platelets in treating infections
US20220168353A1 (en) 2019-08-16 2022-06-02 Cellphire Inc. Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathy
WO2022178177A1 (en) 2021-02-17 2022-08-25 Cellphire, Inc. Freeze-dried platelet derivative compositions for treating antiplatelet-induced coagulopathy
AU2020333666A1 (en) 2019-08-16 2022-03-31 Cellphire, Inc. Thrombosomes as an anticoagulant reversal agent
WO2023081804A1 (en) 2021-11-04 2023-05-11 Cellphire, Inc. Platelet derivative compositions, and methods of making and using such compositions
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN AGENT FOR REMOVING THE THROMBOCYTE AGGREGATION-INHIBITING EFFECT
WO2021046409A1 (en) 2019-09-05 2021-03-11 Cellphire, Inc. Materials and methods for blood plasma preparations
WO2021108539A1 (en) 2019-11-27 2021-06-03 Cellphire, Inc. Platelet diagnostic imaging agents
WO2021108538A1 (en) 2019-11-27 2021-06-03 Cellphire, Inc. PLATELETS LOADED WITH mRNA
EP4101056A4 (en) 2020-02-03 2024-02-28 Malta Inc. Pumped heat electric storage system with dual-clutch powertrain system
WO2021158645A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Methods of treating congenital hemophilia with anti-fibrinolytic loaded platelets
WO2021232015A1 (en) 2020-05-15 2021-11-18 Cellphire, Inc. Platelet derived extracellular vesicles
WO2022103861A1 (en) 2020-11-10 2022-05-19 Cellphire, Inc. Freeze-dried peripheral blood mononuclear cell compositions and methods
US20220279777A1 (en) 2021-02-17 2022-09-08 Cellphire Inc. Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy
US20220273724A1 (en) 2021-02-17 2022-09-01 Cellphire Inc. Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathy
WO2022178191A1 (en) 2021-02-17 2022-08-25 Cellphire, Inc. Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy
CN113101737B (zh) * 2021-03-04 2023-09-15 京美生命科技(杭州)有限公司 一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用
US20230149467A1 (en) 2021-11-04 2023-05-18 Cellphire, Inc. Platelet derivative compositions, and methods of making and using such compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509924A (ja) 2004-08-12 2008-04-03 アドライフ インコーポレイテッド 凍結乾燥血小板の調製法、凍結乾燥血小板を含む組成物、および使用法
US20120125847A1 (en) 2010-11-23 2012-05-24 Biovec Transfusion, Llc Methods for removing pathogens from a platelet preparation
WO2014084263A1 (ja) 2012-11-30 2014-06-05 東レ株式会社 人工保存液置換血小板溶液の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Transfusion，2013年，Vol.53，pp.100S-106S

Also Published As

Publication number Publication date
SG11202112054WA (en) 2021-11-29
EP3962499A1 (en) 2022-03-09
WO2020227149A1 (en) 2020-11-12
IL287716A (en) 2021-12-01
CA3138529C (en) 2025-10-07
KR20220016092A (ko) 2022-02-08
US11529587B2 (en) 2022-12-20
AU2023210528A1 (en) 2023-08-17
US20230158455A1 (en) 2023-05-25
BR112021021984A2 (pt) 2022-03-03
IL322149A (en) 2025-09-01
US11752468B2 (en) 2023-09-12
NZ782598A (en) 2024-05-31
US20230226493A1 (en) 2023-07-20
JP2025081548A (ja) 2025-05-27
EP3962499A4 (en) 2023-01-25
AU2020267368A1 (en) 2021-12-23
IL287716B1 (en) 2025-08-01
CN114072159A (zh) 2022-02-18
AU2020267368B2 (en) 2023-05-04
CA3138529A1 (en) 2020-11-12
JP2022532262A (ja) 2022-07-13
IL287716B2 (en) 2025-12-01
US20200346167A1 (en) 2020-11-05
US20230356150A1 (en) 2023-11-09
US11813572B2 (en) 2023-11-14

Similar Documents

Publication Publication Date Title
JP7640531B2 (ja) 血液製剤を生産するための材料及び方法
US8097403B2 (en) Freeze-dried platelets, method of making and method of use as a diagnostic agent
US12290532B2 (en) Treatment of von Willebrand disease
US20230112136A1 (en) Canine blood platelet preparations
US20200291356A1 (en) Canine blood platelet preparations
US20230149467A1 (en) Platelet derivative compositions, and methods of making and using such compositions
US12370219B2 (en) Platelet derivative compositions, and pluralities of containers containing same
WO2023081804A1 (en) Platelet derivative compositions, and methods of making and using such compositions
US20190076478A1 (en) Canine blood platelet preparations
WO2022178191A1 (en) Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathy
WO2023220739A1 (en) Platelet derivative compositions for use in subjects afflicted with hermansky pudlak syndrome or bernard soulier syndrome
WO2022178177A1 (en) Freeze-dried platelet derivative compositions for treating antiplatelet-induced coagulopathy
RU2850504C2 (ru) Материалы и способы получения продуктов на основе крови
US20250064856A1 (en) Methods for administering platelet derivative compositions to subjects afflicted with hermansky pudlak syndrome or bernard soulier syndrome
JP2024507362A (ja) 抗血小板誘発性凝固障害を治療するためのフリーズドライ血小板誘導体組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230501

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230529

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240411

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241010

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250117

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250220

R150 Certificate of patent or registration of utility model

Ref document number: 7640531

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150